Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01075672 · ClinicalTrials.gov registry record · NA

Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals

A NA study of Depression and Post Traumatic Stress Disorder, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT01075672 is a NA study of Depression and Post Traumatic Stress Disorder that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 250 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01075672, a NA study of Depression and Post Traumatic Stress Disorder, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

To examine the effectiveness and clinical care outcomes of cognitive-behavioral therapy interventions at Massachusetts General Hospital (MGH).

Interventions

  • BEHAVIORAL Cognitive behavioral therapy (CBT)

Study Locations (1)

Massachusetts

  • Cognitive-Behavioral Therapy and Behavioral Medicine Programs, Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2010-01
Est. Completion 2027-01
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01075672

The ClinicalTrials.gov registry entry for NCT01075672 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (68% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Cognitive behavioral therapy (CBT) is the first listed.

NCT01075672 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01075672 about?

NCT01075672 is a clinical study titled "Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals". To examine the effectiveness and clinical care outcomes of cognitive-behavioral therapy interventions at Massachusetts General Hospital (MGH).

What is the current status of trial NCT01075672?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2010-01. Estimated completion is 2027-01.

What conditions does trial NCT01075672 study?

This clinical trial studies the following conditions: Depression, Post Traumatic Stress Disorder, Attention Deficit Hyperactivity Disorder, Obsessive - Compulsive Disorder, Generalized Anxiety Disorder.

What interventions are being tested in trial NCT01075672?

The interventions under investigation include: Cognitive behavioral therapy (CBT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01075672?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01075672 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.